COVID-19

Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.

On the next episode of The Road to a Vaccine, host Lisa Ling delves into how the pandemic is affecting parents, children and school staff. We sat down with one of the upcoming guests, school nurse Robin Cogan, to find out the most pressing questions on her mind—and those of moms and dads.

In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.

From epidemic masks that the company introduced during the Spanish flu pandemic to work it’s doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company’s culture.

On the latest episode of The Road to a Vaccine, host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.

Within a matter of weeks, Ramon Polo’s work and home life were completely changed by the novel coronavirus—and he’s a stronger scientist and husband for it.

Watch a video of Gorsky’s interview at the virtual summit, which includes the latest information on the company’s pursuit of a potential COVID-19 vaccine.

The clinical trial has completed full immunizations of the company’s investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.